Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorPersaud, Nav
dc.contributor.authorBedard, Michael
dc.contributor.authorBoozary, Andrew
dc.contributor.authorGlazier, Richard H
dc.contributor.authorGomes, Tara
dc.contributor.authorHwang, Stephen W
dc.contributor.authorJüni, Peter
dc.contributor.authorLaw, Michael R
dc.contributor.authorMamdani, Muhammad
dc.contributor.authorManns, Braden
dc.contributor.authorMartin, Danielle
dc.contributor.authorMorgan, Steven G
dc.contributor.authorOh, Paul
dc.contributor.authorPinto, Andrew D
dc.contributor.authorShah, Baiju R
dc.contributor.authorSullivan, Frank
dc.contributor.authorUmali, Norman
dc.contributor.authorThorpe, Kevin E
dc.contributor.authorTu, Karen
dc.contributor.authorWu, Fangyun
dc.contributor.authorLaupacis, Andreas
dc.contributor.authorCLEAN Meds study team
dc.date.accessioned2023-06-06T14:30:06Z
dc.date.available2023-06-06T14:30:06Z
dc.date.issued2023-05-26
dc.identifier286917626
dc.identifier0b8ec2d2-18d2-4f94-abf2-a42b6b19a760
dc.identifier37234014
dc.identifier85160455757
dc.identifier37234014
dc.identifier.citationPersaud , N , Bedard , M , Boozary , A , Glazier , R H , Gomes , T , Hwang , S W , Jüni , P , Law , M R , Mamdani , M , Manns , B , Martin , D , Morgan , S G , Oh , P , Pinto , A D , Shah , B R , Sullivan , F , Umali , N , Thorpe , K E , Tu , K , Wu , F , Laupacis , A & CLEAN Meds study team 2023 , ' Effect of free medicine distribution on health care costs in Canada over 3 years : a secondary analysis of the CLEAN meds randomized clinical trial ' , JAMA Health Forum , vol. 4 , no. 5 , e231127 . https://doi.org/10.1001/jamahealthforum.2023.1127en
dc.identifier.issn2689-0186
dc.identifier.otherPubMedCentral: PMC10220517
dc.identifier.otherORCID: /0000-0002-6623-4964/work/136288936
dc.identifier.urihttps://hdl.handle.net/10023/27753
dc.descriptionFunding: This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and the Ministry of Long-Term Care. This study also received funding from the Canadian Institutes of Health Research. Parts of the study data were compiled and provided by the Canadian Institute for Health Information and the Ontario Ministry of Health. This work is supported by the Canadian Institutes of Health Research (381409), the Ontario SPOR Support Unit (OSSU), and the St Michael’s Hospital Foundation.en
dc.description.abstractIMPORTANCE : Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE : To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS : This secondary analysis of a multicenter randomized clinical trial using a prespecified outcome took place across 9 primary care sites in Ontario, Canada (6 in Toronto and 3 in rural areas), where health care services are generally publicly funded. Adult patients (≥18 years old) reporting cost-related nonadherence to medicines in the past 12 months were recruited between June 1, 2016, and April 28, 2017, and followed up until April 28, 2020. Data analysis was completed in 2021. INTERVENTIONS : Access to a comprehensive list of 128 medicines commonly prescribed in ambulatory care with no out-of-pocket costs for 3 years vs usual medicine access. MAIN OUTCOME AND MEASURES : Total publicly funded health care costs over 3 years, including costs of hospitalizations. Health care costs were determined using administrative data from Ontario's single-payer health care system, and all costs are reported in Canadian dollars with adjustments for inflation. RESULTS : A total of 747 participants from 9 primary care sites were included in the analysis (mean [SD] age, 51 [14] years; 421 [56.4%] female). Free medicine distribution was associated with a lower median total health care spending over 3 years of $1641 (95% CI, $454-$2792; P = .006). Mean total spending was $4465 (95% CI, -$944 to $9874) lower over the 3-year period. CONCLUSIONS AND RELEVANCE : In this secondary analysis of a randomized clinical trial, eliminating out-of-pocket medication expenses for patients with cost-related nonadherence in primary care was associated with lower health care spending over 3 years. These findings suggest that eliminating out-of-pocket medication costs for patients could reduce overall costs of health care. TRIAL REGISTRATION : ClinicalTrials.gov Identifier: NCT02744963.
dc.format.extent8
dc.format.extent690891
dc.language.isoeng
dc.relation.ispartofJAMA Health Forumen
dc.subjectAdulten
dc.subjectHumansen
dc.subjectFemaleen
dc.subjectMiddle ageden
dc.subjectAdolescenten
dc.subjectMaleen
dc.subjectHealth care costsen
dc.subjectHospitalizationen
dc.subjectDelivery of health careen
dc.subjectHealth expendituresen
dc.subjectOntarioen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectHealth Policyen
dc.subjectPublic Health, Environmental and Occupational Healthen
dc.subjectDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectMCCen
dc.subject.lccRMen
dc.subject.lccRA0421en
dc.titleEffect of free medicine distribution on health care costs in Canada over 3 years : a secondary analysis of the CLEAN meds randomized clinical trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Population and Behavioural Science Divisionen
dc.identifier.doi10.1001/jamahealthforum.2023.1127
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record